Induced pluripotent stem cells: Developmental biology to regenerative medicine

Timothy J. Nelson, Almudena Martinez-Fernandez, Andre Terzic

Research output: Contribution to journalReview articlepeer-review

112 Scopus citations


Nuclear reprogramming of somatic cells with ectopic stemness factors to bioengineer pluripotent autologous stem cells signals a new era in regenerative medicine. The study of developmental biology has provided a roadmap for cardiac differentiation from embryonic tissue formation to adult heart muscle rejuvenation. Understanding the molecular mechanisms of stem-cell-derived cardiogenesis enables the reproducible generation, isolation, and monitoring of progenitors that have the capacity to recapitulate embryogenesis and differentiate into mature cardiac tissue. With the advent of induced pluripotent stem (iPS) cell technology, patient-specific stem cells provide a reference point to systematically decipher cardiogenic differentiation through discrete stages of development. Interrogation of iPS cells and their progeny from selected cohorts of patients is an innovative approach towards uncovering the molecular mechanisms of disease. Thus, the principles of cardiogenesis can now be applied to regenerative medicine in order to optimize personalized therapeutics, diagnostics, and discovery-based science for the development of novel clinical applications.

Original languageEnglish (US)
Pages (from-to)700-710
Number of pages11
JournalNature Reviews Cardiology
Issue number12
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Induced pluripotent stem cells: Developmental biology to regenerative medicine'. Together they form a unique fingerprint.

Cite this